5th Annual Henry Ford Gastroenterology and Hepatology Symposium - 4/23/22

The 5th Annual Henry Ford Gastroenterology and Hepatology symposium provides an evidence-based update on the diagnosis and management of complex gastrointestinal and hepatologic disorders. Expert faculty will review current therapeutic advances in chronic hepatitis B, metabolic dysfunction–associated steatotic liver disease, and inflammatory bowel disease, including emerging medical therapies and management of disease-related complications. Additional sessions address complementary and alternative therapies in liver disease, pancreatic fluid collections, gastrointestinal motility and defecatory disorders, and evolving diagnostic and treatment strategies for Barrett’s esophagus, primary sclerosing cholangitis, small intestinal bacterial overgrowth, and cholangiocarcinoma. Through case-based discussion and practical guidance, this activity supports clinicians in applying current evidence to improve patient outcomes across a spectrum of digestive diseases.

1. Summarize current therapeutic advances in the management of chronic hepatitis B.
2. Describe evidence-based management strategies for non-alcoholic fatty liver disease (NAFLD/NASH).
3. Evaluate the evidence, role, and safety considerations of complementary and alternative therapies in liver disease.
4. Review diagnosis and management of IBD related strictures
5. Discuss current and emerging medical therapies for inflammatory bowel disease and their clinical applications.
6. Identify recent advances in the evaluation and management of gastrointestinal motility disorders.
7. Apply diagnostic criteria and treatment strategies for defecatory disorders.
8. Describe indications and management strategies for pancreatic fluid collections.
9. Summarize current diagnostic and therapeutic updates in Barrett’s esophagus, primary sclerosing cholangitis, small intestinal bacterial overgrowth, and cholangiocarcinoma.

Henry Ford Health is accredited by the Accreditation Council for Continuing Medical Education (ACCME) to provide continuing medical education for physicians.

Designation Statement: Henry Ford Health designates this Live Activity for a maximum of 8.25 AMA PRA Category 1 Credit™(s). Physicians should claim only the credit commensurate with the extent of their participation in the activity. 

ABIM MOC Part 2: Successful completion of this CME activity, which includes participation in the evaluation component, enables the participant to earn up to 8.25 MOC points in the American Board of Internal Medicine’s (ABIM) Maintenance of Certification (MOC) program. It is the CME activity provider’s responsibility to submit participant completion information to ACCME for the purpose of granting ABIM MOC credit.

Accessibility Statement

The Henry Ford Health Office of Continuing Medical Education is committed to ensuring that its programs, services, goods, and facilities are accessible to individuals with disabilities as specified under Section 504 of the Rehabilitation Act and the ADA Amendments Act of 2008. If you have needs that require special accommodations, please contact [email protected]. 

Cancellation Policy

The Henry Ford Health Office of Continuing Medical Education reserves the right to cancel or postpone this program if necessary; in the event of cancellation, course fees will be fully refunded. We are not responsible for other costs incurred such as non-refundable airline tickets or hotel penalties. Please send cancellation requests to [email protected]. 

The Henry Ford Health System Office of Continuing Medical Education adheres to ACCME Criteria, Standards and Policies regarding industry support of continuing medical education. Disclosure of faculty and their commercial relationships will be made prior to the activity.

Mitigation of Relevant Financial Relationships

Henry Ford Health adheres to the ACCME’s Standards for Integrity and Independence in Accredited Continuing Education. Henry Ford Health has implemented mechanisms to identify and mitigate financial relationships with ineligible companies for all individuals in a position to control content of this activity. All relevant financial relationships have been mitigated prior to the commencement of this activity.

Saturday, April 23, 2022